RESEARCH-USE BIOSIMILAR ANTIBODY
Crenezumab
Monoclonal antibody · IgG4
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research.
TARGETAPP
YMonoclonal antibody
CATALOGSC-BS-662
CATALOG NUMBERSC-BS-662
MOLECULAR WEIGHTApprox. 143.32 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research.
Crenezumab is a recombinant research-use antibody directed against APP.